ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ICUI vs IRTC // 10Y YIELD & FRED MACRO BETA

ICU Medical Inc. (NASDAQ) VS. iRhythm Holdings Inc. (NASDAQ) • 15-METRIC TALLY: ICUI 6 — IRTC 3
■ METRIC PARITY
macro-sensitivity
—
macro-sensitivity
0.98
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ICUI VS. IRTC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ICUI IRTC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 36.80% 70.60% -33.80 IRTC /gross-margins <GO>
Return on Invested Capital (ROIC) 1.00% -13.50% +14.50 ICUI /roic <GO>
EV/EBITDA & P/E Valuation 46.6x — — TIE /valuation <GO>
Free Cash Flow Yield 2.18% 0.82% +1.36 ICUI /fcf-yield <GO>
Operating Margin 1.90% -7.70% +9.60 ICUI /operating-margins <GO>
Net Profit Margin 0.00% -6.00% +6.00 ICUI /net-margins <GO>
Revenue Growth (YoY) -6.30% 26.20% -32.50 IRTC /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 3.01 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 8/9 7/9 +1.00 ICUI /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 49.6 58.9 -9.30 IRTC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — 0.98 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 30.0x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $4.10B $4.07B $29.0M ICUI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ICUI REV IRTC REV ICUI GROSS % IRTC GROSS % ICUI FCF IRTC FCF
FY 2025 $2.23B $747.1M 36.8% 70.6% $91.8M $34.5M
FY 2024 $2.38B $591.8M 34.6% 68.9% $124.7M -$30.6M
FY 2023 $2.26B $492.7M — — $166.2M -$72.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ICUI // BETA —
IRTC // BETA 0.98